Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrin subunit alpha-8 (ITGA8) encodes the alpha-8 subunit of the heterodimeric integrin alpha-8/beta-1 receptor, a member of the integrin family of transmembrane glycoproteins that mediate cell adhesion and cell signaling. Integrin alpha-8 plays a crucial role in the formation of the kidney and other organs by regulating the recruitment of mesenchymal cells into developing epithelial structures. It recognizes R-G-D (arginine-glycine-aspartic acid) motifs in ligands such as tenascin-C (TNC), fibronectin (FN1), osteopontin (SPP1), and vitronectin (VTN), and is especially important in mediating cell-cell and cell-matrix interactions vital for organogenesis and wound healing. ITGA8 deficiency or mutation is associated with human renal developmental disorders and is supported by animal models showing increased susceptibility to chronic kidney disease. Additionally, it may contribute to cytoskeletal remodeling, signal transduction pathways, and neuronal outgrowth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrin subunit alpha-8 (ITGA8).